Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark E. Cooper
Diabetic Kidney Disease
Nature Reviews Disease Primers
Medicine
miR-200a Prevents Renal Fibrogenesis Through Repression of TGF- 2 Expression
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Angiotensin II Type 2 Receptor Agonist Compound 21 Is Protective in Experimental Diabetes-Associated Atherosclerosis
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Hypertension
Internal Medicine
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of Its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus
Hypertension
Internal Medicine
NOX4-derived Reactive Oxygen Species Limit Fibrosis and Inhibit Proliferation of Vascular Smooth Muscle Cells in Diabetic Atherosclerosis
Free Radical Biology and Medicine
Biochemistry
Physiology
Plasma Advanced Glycation End Products (AGEs) and NF-κB Activity Are Independent Determinants of Diastolic and Pulse Pressure
Clinical Chemistry and Laboratory Medicine
Biochemistry
Medicine
Clinical Biochemistry
Nox-4 Deletion Reduces Oxidative Stress and Injury by PKC- -Associated Mechanisms in Diabetic Nephropathy
Physiological Reports
Physiology
Diabetes-Induced Vascular Hypertrophy Is Accompanied by Activation of Na+-H+ Exchange and Prevented by Na+-H+ Exchange Inhibition
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Hypertension
Internal Medicine
1
2
›
